Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review
It is considered that COVID-19’s pandemic expansion is responsible for the particular increase in deaths, especially among the population with comorbidities. The health system is often overwhelmed by the large number of cases of patients addressing it, by the regional limitation of funds, and by the...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Clinical Practice |
| Online Access: | http://dx.doi.org/10.1155/2022/1571826 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695291697004544 |
|---|---|
| author | Andreea Fitero Simona Gabriela Bungau Delia Mirela Tit Laura Endres Shamim Ahmad Khan Alexa Florina Bungau Ioana Romanul Cosmin Mihai Vesa Andrei-Flavius Radu Alexandra Georgiana Tarce Mihaela Alexandra Bogdan Aurelia Cristina Nechifor Nicoleta Negrut |
| author_facet | Andreea Fitero Simona Gabriela Bungau Delia Mirela Tit Laura Endres Shamim Ahmad Khan Alexa Florina Bungau Ioana Romanul Cosmin Mihai Vesa Andrei-Flavius Radu Alexandra Georgiana Tarce Mihaela Alexandra Bogdan Aurelia Cristina Nechifor Nicoleta Negrut |
| author_sort | Andreea Fitero |
| collection | DOAJ |
| description | It is considered that COVID-19’s pandemic expansion is responsible for the particular increase in deaths, especially among the population with comorbidities. The health system is often overwhelmed by the large number of cases of patients addressing it, by the regional limitation of funds, and by the gravity of cases at subjects suffering from this pathology. Several associated conditions including diabetes, cardiovascular illnesses, obesity, persistent lung condition, neurodegenerative diseases, etc., increase the mortality risk and hospitalization of subjects suffering from COVID-19. The rapid identification of patients with increased risk of death from the SARS-CoV-2 virus, the stratification in accordance with the risk and the allocation of human, financial, and logistical resources in proportion must be a priority for health systems worldwide. |
| format | Article |
| id | doaj-art-d6dd99397ced479da3d9dee0a977817c |
| institution | DOAJ |
| issn | 1742-1241 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Clinical Practice |
| spelling | doaj-art-d6dd99397ced479da3d9dee0a977817c2025-08-20T03:19:49ZengWileyInternational Journal of Clinical Practice1742-12412022-01-01202210.1155/2022/1571826Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic ReviewAndreea Fitero0Simona Gabriela Bungau1Delia Mirela Tit2Laura Endres3Shamim Ahmad Khan4Alexa Florina Bungau5Ioana Romanul6Cosmin Mihai Vesa7Andrei-Flavius Radu8Alexandra Georgiana Tarce9Mihaela Alexandra Bogdan10Aurelia Cristina Nechifor11Nicoleta Negrut12Doctoral School of Biomedical SciencesDoctoral School of Biomedical SciencesDoctoral School of Biomedical SciencesDepartment of Psycho-Neuroscience and RecoveryFaculty of Medicine and PharmacyFaculty of Medicine and PharmacyDepartment of Dental MedicineDepartment of Preclinical DisciplinesDepartment of PharmacyFaculty of Medicine and PharmacyDepartment of PharmacyAnalytical Chemistry and Environmental Engineering DepartmentDepartment of Psycho-Neuroscience and RecoveryIt is considered that COVID-19’s pandemic expansion is responsible for the particular increase in deaths, especially among the population with comorbidities. The health system is often overwhelmed by the large number of cases of patients addressing it, by the regional limitation of funds, and by the gravity of cases at subjects suffering from this pathology. Several associated conditions including diabetes, cardiovascular illnesses, obesity, persistent lung condition, neurodegenerative diseases, etc., increase the mortality risk and hospitalization of subjects suffering from COVID-19. The rapid identification of patients with increased risk of death from the SARS-CoV-2 virus, the stratification in accordance with the risk and the allocation of human, financial, and logistical resources in proportion must be a priority for health systems worldwide.http://dx.doi.org/10.1155/2022/1571826 |
| spellingShingle | Andreea Fitero Simona Gabriela Bungau Delia Mirela Tit Laura Endres Shamim Ahmad Khan Alexa Florina Bungau Ioana Romanul Cosmin Mihai Vesa Andrei-Flavius Radu Alexandra Georgiana Tarce Mihaela Alexandra Bogdan Aurelia Cristina Nechifor Nicoleta Negrut Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review International Journal of Clinical Practice |
| title | Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review |
| title_full | Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review |
| title_fullStr | Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review |
| title_full_unstemmed | Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review |
| title_short | Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review |
| title_sort | comorbidities associated diseases and risk assessment in covid 19 a systematic review |
| url | http://dx.doi.org/10.1155/2022/1571826 |
| work_keys_str_mv | AT andreeafitero comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT simonagabrielabungau comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT deliamirelatit comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT lauraendres comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT shamimahmadkhan comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT alexaflorinabungau comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT ioanaromanul comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT cosminmihaivesa comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT andreiflaviusradu comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT alexandrageorgianatarce comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT mihaelaalexandrabogdan comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT aureliacristinanechifor comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview AT nicoletanegrut comorbiditiesassociateddiseasesandriskassessmentincovid19asystematicreview |